New drug offers hope for rosacea sufferers with burning pain
NCT ID NCT07606820
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 3 times
Summary
This study looks at whether Cligabalin (HSK16149) can help people with a type of rosacea that causes severe burning and tingling on the face. It includes 60 adults whose redness and discomfort did not improve with standard treatments. The main goal is to see if the drug reduces facial redness and eases those painful sensations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROSACEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Nanjing, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can light therapy or special skincare tame rosacea redness? a trial puts them to the test
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- Can a special cream soothe rosacea redness?
- Rosacea mystery: gut and skin bacteria under the microscope
- Ear stimulation device could tame rosacea flushing
- Scientists probe blood vessel role in skin disorders